The 20 Best Pseudomyxoma Peritonei Doctors near Chestnut Hill, MA

Dr. Melnitchouk is an associate surgeon at Brigham and Women’s Hospital (BWH) and Brigham and Women’s Faulkner Hospital (BWFH) and assistant professor of surgery at Harvard Medical School.Dr. Melnitchouk received her medical degree from Albert Einstein College of Medicine. She completed her general surgery residency at Brigham and Women’s Hospital/Harvard Medical School. As a resident, she received the Rudolph Vollman Award for excellence in teaching and contributed to multiple HMS research projects on colon and rectal surgery procedures. She completed a colorectal surgery fellowship at the combined Memorial Sloan Kettering Cancer Center and New York Hospital/Weill Cornell Medical Center Colorectal Surgery Program. She is board-certified in general surgery and Colon and Rectal Surgery.She founded and leads a Program in Peritoneal Surface Malignancy, focusing on treating patients with appendiceal cancer, colorectal cancer, and peritoneal mesothelioma through a multidisciplinary personalized approach emphasizing shared decision-making. Dr. Melnitchouk is a highly experienced surgeon offering cytoreduction and heated intraperitoneal chemotherapy (HIPEC) to patients with peritoneal surface malignancy and leads a research program with an emphasis on early recovery and clinical trials. Her other research interests are global health, colorectal cancer screening and surgery for colorectal cancer in low-to-middle-income countries, quality, and safety. Her clinical interests include minimally invasive surgery (laparoscopic, robotic, and combined endoscopic, laparoscopic surgery), sphincter preserving/saving surgery in rectal cancer, colon and rectal cancer, and inflammatory bowel disorders. Dr. Melnitchouk is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Anal Cancer, Appendectomy, and Ureteroscopy.

Umut Sarpel is an Oncologist in Boston, Massachusetts. Dr. Sarpel is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Gallbladder Cancer, Gallbladder Disease, Gastrointestinal Stromal Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Meghan Shea is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Shea is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Endometrial Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Small Cell Lung Cancer (SCLC).

Dr. Mayer received her medical degree from Harvard Medical School, completed her residency in Internal Medicine at Brigham and Women's Hospital, and her fellowship in Medical Oncology at the Dana-Farber Cancer Institute. She also obtained a Masters in Public Health from the Harvard School of Public Health. She joined the staff of Dana-Farber and Brigham and Women's Hospital in 2006, where she serves as Director of Breast Cancer Clinical Research. She is a breast cancer medical oncologist and clinical investigator leading research studies focused on novel therapies for the treatment of breast cancer. Dr. Mayer is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.

Dr. Leone received his MD from Universidad del Salvador, Argentina in 2005. He completed his residency in Internal Medicine at University of Miami Jackson Memorial Hospital in 2011, and went on to complete fellowships in Hematology and Medical Oncology at University of Pittsburgh Medical Center in 2014. He was faculty at University of Iowa Hospitals and Clinics from 2014 through 2017. In 2017, he joined the staff of Brigham and Women's Hospital and Dana-Farber, where he is a medical oncologist and clinical investigator in the Breast Oncology Center. His research focuses on brain metastases, male breast cancer and novel therapies in the treatment of breast cancer. Dr. Leone is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Breast Cancer in Men, Breast Cancer, Brain Tumor, and Inflammatory Breast Cancer.

Dr. Tolaney is Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, and Associate Professor of Medicine at Harvard Medical School.  She is a breast medical oncologist whose research focuses on the development of novel therapies in the treatment of breast cancer.  She has been instrumental in developing several treatment approaches for breast cancer, including approaches focused on tailoring therapy for early stage HER2+ disease, use of cdk 4/6 inhibitors, antibody drug conjugates, and immunotherapy.She is a member of the National Cancer Institute Breast Cancer Steering Committee and is Vice Chair for Late-Stage Development in Breast Cancer in the Alliance for Clinical Trials in Oncology. Her research has been funded by the Breast Cancer Research Foundation and Susan G. Komen. She currently chairs multiple phase 3 trials in breast cancer and serves on several steering committees for practice-changing trials.  Her work has been published in journals such as the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology, and others. She received her undergraduate degree from Princeton University in 1998 and her medical degree from UC San Francisco in 2002. She subsequently completed her residency in Internal Medicine at Johns Hopkins University, and fellowships in hematology and medical oncology at Dana-Farber Cancer Institute. She obtained a Masters in Public Health from the Harvard School of Public Health in 2007. In 2008, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital. Dr. Tolaney is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Triple-Negative Breast Cancer.

Susan Schumer is an Oncologist in Boston, Massachusetts. Dr. Schumer is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Angiosarcoma, and Paget Disease of the Breast.

Michael Muto is an Obstetrics and Gynecologist in Boston, Massachusetts. Dr. Muto is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Endometrial Cancer, Ovarian Cancer, Endometrial Stromal Sarcoma, Hysterectomy, and Oophorectomy.

Dr. Raut is the Chief of the Division of Surgical Oncology and the inaugural Distinguished Chair for Cancer Care at Brigham and Women's Hospital. He received a BA and BS from Stanford University, MSc from University of Oxford, and MD from Harvard Medical School, where he is also a Professor of Surgery. He completed his residency in general surgery at Massachusetts General Hospital and fellowship in surgical oncology at MD Anderson Cancer Center. Dr. Raut specializes in the multidisciplinary care of patients with soft tissue sarcoma and serves as the Surgery Director for the Center for Sarcoma and Bone Oncology at Dana-Farber Brigham Cancer Center (DFBCC). His research focuses on multimodal strategies to reduce rates of local recurrence for patients with sarcoma. Dr. Raut is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Adult Soft Tissue Sarcoma, Gastrointestinal Stromal Tumor, Angiosarcoma, Nephrectomy, and Pancreaticoduodenectomy.

Jiping Wang is a Surgical Oncologist in Boston, Massachusetts. Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Stomach Cancer, Pancreatic Cancer, Adult Soft Tissue Sarcoma, Pancreatectomy, and Small Bowel Resection.

Dr. Shimizu is the director of PICC services, an acute care and trauma surgeon and a surgical intensivist in the Division of Trauma, Burn and Surgical Critical Care and Emergency General Surgery at Brigham and Women’s Hospital.Prior to her current role, Dr. Shimizu was an associate surgeon in the Division of General and Gastrointestinal Surgery at Brigham and Women’s Hospital. She received her bachelor’s degree from the University of California and her medical degree from the John A. Burns School of Medicine at the University of Hawaii. She completed her general surgery residency and a surgical oncology research fellowship at the University of California. She completed an acute care and surgical critical care fellowship at Brigham and Women’s Hospital.Dr. Shimizu’s work in the PICC program has included creating and implementing clinical protocols and superior standards of care. Her research interests focus on the clinical outcomes for trauma patients and is heavily involved with residency wellness and professional development programs. Dr. Shimizu is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Gastrointestinal Perforation, Delirium, Ogilvie Syndrome, Gastrostomy, and Colostomy.

Page Widick is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Widick is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Endometrial Cancer, Desmoplastic Small Round Cell Tumor, Ovarian Carcinosarcoma, and Sertoli-Leydig Cell Tumor.

Ahmed Rattani is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Rattani is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Familial Colorectal Cancer, Pancreatic Cancer, Anal Cancer, and Liver Cancer.

Panagiotis Fidias is an Internal Medicine provider in Boston, Massachusetts. Dr. Fidias is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Familial Colorectal Cancer, and Colorectal Cancer.

Bruno Bockorny is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Bockorny is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Familial Pancreatic Cancer, Pancreatic Cancer, Gastroesophageal Junction Cancer, and Bone Tumor.

Andrew Wiechert is an Obstetrics and Gynecologist in Boston, Massachusetts. Dr. Wiechert is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Endometrial Cancer, Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Ovarian Cancer, and Hysterectomy.

Leslie Garrett is an Obstetrics and Gynecologist in Boston, Massachusetts. Dr. Garrett is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Bladder Reconstruction, and Hysterectomy.

Joseph Dottino is an Obstetrics and Gynecologist in Boston, Massachusetts. Dr. Dottino is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Endometrial Cancer, Ovarian Cancer, Malignant Mixed Mullerian Tumor, Splenectomy, and Intrauterine Device Insertion.

Peter Whooley is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Whooley has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Chromophobe Renal Cell Carcinoma, Anal Cancer, Stomach Cancer, and Pancreatic Cancer.

Matthew Abrams is a Radiologist in Boston, Massachusetts. Dr. Abrams is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Anal Cancer, Familial Pancreatic Cancer, Ampullary Cancer, and Pancreatic Cancer.